Biotech

Ocugen’s stock soars after Bharat Biotech partner candidate COVID-19 vaccine shows 81% effectiveness

Ocugen COVID-19 vaccine co-development partner, Bharat Biotech shares COVAXIN Phase 3 interim results, demonstrates 81% effectiveness Nasdaq: OCGN

Ocugen COVID-19 vaccine co-development partner, Bharat Biotech shares COVAXIN Phase 3 interim results, demonstrates 81% effectiveness

India asks Bharat Biotech to send data on the effectiveness of ongoing Covaxin phase 3 studies

Brazil to buy 20 million COVID-19 vaccines from India Bharat Biotech

Indian state rejects approved Bharat Biotech vaccine without efficacy data

China approves Sinovac Biotech COVID-19 vaccine for general public use

Coronavirus Update (COVID-19): FDA Announces Meeting of Janssen Biotech Inc.’s COVID-19 Vaccine Candidate to Discuss Vaccine Candidate

Coronavirus Update (COVID-19): FDA Announces Meeting of Janssen Biotech Inc.’s COVID-19 Vaccine Candidate to Discuss Vaccine Candidate

Biotech Launches Human Tests for Potential ‘Barrier’ for Covid-19 Vaccines

3 best biotech choices for 2021

Which biotech stock is the best choice for 2021?